In the country’s second most populous state, only three entities are licensed to provide medical cannabis — and only products low in THC.
Under new rules, a limited “low-THC” medical program must coexist with retail products in a somewhat blurry regulatory framework.
Cannabis Wire has found that major cannabis companies, like Canopy Growth, are registered to lobby.
Countless new patients could now qualify for the state’s Compassionate Use Program—but activists and Democratic lawmakers say the reforms don’t go far enough.
Two bills headed out of the Texas House have advocates hopeful, but the Senate has sent mixed messages. The state has edged up to cannabis reform before, only to retreat.
When it comes to cannabis, even the consequential congressional midterm elections here serve as a primer for the main event, when the Texas General Assembly reconvenes next year.
A fundraising push promised by Rob Kampia, the former head of Marijuana Policy Project, one of the nation's largest and oldest pro-legalization groups, fell flat.